$19.76 Billion Immunoassay Markets, 2025 by Product (Kits & Reagents, Analyzers, Software), Platform (Chemiluminescence, Radioimmunoassays) Application (Infectious Diseases, Cardiology) - ResearchAndMarkets.com
Summary
DUBLIN--(BUSINESS WIRE)--The "Immunoassay Market by Product (Kits & Reagents, Analyzers, Software), Platform (Chemiluminescence, Radioimmunoassays) Application (Infectious Diseases, Cardiology), End User (Hospitals, Academic Laboratories), and Geography - Global Forecast to 2025" report has been added to ResearchAndMarkets.coms offering. On the basis of product, immunoassay kits and reagents segment is estimated to account for the largest share of this market in 2019. The large share of this segment is mainly attributed to the increasing number of immunoassay tests being performed across the globe leading to the recurrent purchase of kits and reagents. The high growth of this segment can be attributed to the rising global incidence of chronic diseases, increasing vaccine development to address the challenge of antimicrobial resistance, and technological advancements in ELISpot assay kits and analyzers. North America accounted for the largest share of immunoassays market, mainly due to rising incidence of infectious diseases, growing prevalence of cancer, rising healthcare expenditure, presence of major players for immunoassay in the region, and highly developed healthcare infrastructure.